Sesques P, Houot R, Al Tabaa Y, Le Bras F, Ysebaert L, Choquet S, Jardin F, Bay J-O, Gros F-X, Morschhauser F, Rossi C, Gastinne T, Thieblemont C, Joris M, Ricard L, Regny C, La Rochelle LD, Feugier P, Marcais A, Griolet S, Tarte K, Laurent C, Cartron G. Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse. haematol [Internet]. 2020Sep.10 [cited 2026May25];. Available from: https://haematologica.org/article/view/14188